Actively Recruiting

Phase Not Applicable
Age: 24Weeks - 42Weeks
All Genders
NCT07514481

LISA vs Endotracheal Surfactant in Preterm Neonates: A Lung Ultrasound Distribution Study

Led by Hamad General Hospital · Updated on 2026-04-07

22

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective, non-randomized, unblinded pilot study evaluates and compares the intrapulmonary distribution of exogenous surfactant in preterm neonates when administered via Less Invasive Surfactant Administration (LISA) versus conventional endotracheal intubation (ETT). Lung ultrasound (LUS) will be utilized to assess the pioneer Surfactant Distribution Homogeneity Index (SDHI) to quantify the evenness and extent of surfactant-induced lung aeration. Secondary objectives include evaluating changes in LUS scores, short-term clinical respiratory outcomes, and feasibility parameters for guiding future larger-scale trials.

CONDITIONS

Official Title

LISA vs Endotracheal Surfactant in Preterm Neonates: A Lung Ultrasound Distribution Study

Who Can Participate

Age: 24Weeks - 42Weeks
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Gestational age between 24+0 and 42+6 weeks
  • Clinical and radiographic diagnosis of Respiratory Distress Syndrome (RDS)
  • Need for surfactant treatment within the first 3 days of life
  • Written informed parental consent obtained
Not Eligible

You will not qualify if you...

  • Infants intubated at birth or who received prophylactic surfactant in the delivery room
  • Major congenital anomalies or lung malformations such as congenital diaphragmatic hernia or pulmonary hypoplasia
  • Syndromic or genetic conditions affecting lung or chest wall development
  • Severe hemodynamic instability or congenital heart disease requiring intensive support
  • Lack of parental consent for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Women's Wellness and Research Center (WWRC), Hamad Medical Corporation

Doha, Qatar

Actively Recruiting

Loading map...

Research Team

L

Loay A Alkamel, MD, Mac

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here